Product Categories
| Country: | China |
|---|---|
| Tel: | 020-86211473 |
| Mobile: | +8613925088720 |
| E-mail: | linda@aanpharm.com |
| QQ: | 2736941586 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Tecovirimat Monohydrate | C19H17F3N2O4 | 1162664-19-8 | Details |
| 5-Bromoindole-2-carboxylic acid | C9H6BrNO2 | 7254-19-5 | Details |
| Brincidofovir | C27H52N3O7P | 444805-28-1 | Details |
| Volitinib | C17H15N9 | 1313725-88-0 | Details |
| Futibatinib | C22H22N6O3 | 1448169-71-8 | Details |
| 5-BroMo-2-fluoroaniline | C6H5BrFN | 2924-09-6 | Details |
| Pralsetinib | C27H32FN9O2 | 2097132-94-8 | Details |
| Lenacapavir | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| 2-(Dimethylphosphinyl)benzenamine | C8H12NOP | 1197953-47-1 | Details |
| Capivasertinib | C21H25ClN6O2 | 1143532-39-1 | Details |
| ACT-132577 | C16H14Br2N6O4S | 1103522-45-7 | Details |
| Abemaciclib | C20H21F6N7O4S | 1650550-25-6 | Details |
| (S)-5-fluoro-3-methylisobenzofuran-1(3H)-one | C9H7FO2 | 1803573-19-4 | Details |
| Peficitinib hydrobromide | C18H22N4O2. HBr | 1353219-05-2 | Details |
| RMC-6236 | C44H58N8O5S | 2765081-21-6 | Details |
| (2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl)tetrahydro-4,5-dimethyl-5-(trifluoromethyl)-2-furanol | C14H15F5O3 | 2875066-41-2 | Details |
| Methyl 2-amino-4-chloro-5-fluorobenzoate | C8H7ClFNO2 | 104901-79-3 | Details |
| 5-Chloro-4-(trifluoromethyl)pyridin-2-amine hydrochloride | C6H5Cl2F3N2 | 1095824-77-3 | Details |
| Ritlecitinib | C15H19N5O | 1792180-81-4 | Details |
| Tirzepatide | C225H348N48O68 | 2023788-19-2 | Details |
| 1.1'-Binaphthyl-2.2'-diphemyl phosphine | C44H32P2 | 98327-87-8 | Details |
| trans-Zeatin-riboside | C15H21N5O5 | 6025-53-2 | Details |
| Dabrafenib | C23H20F3N5O2S2 | 1195765-45-7 | Details |
| Tucatinib | C26H24N8O2 | 937263-43-9 | Details |
| 2,5-Dichloro-N-[2-(dimethylphosphinyl)phenyl]-4-pyrimidinamine | C12H12Cl2N3OP | 1197953-49-3 | Details |
| Ivosidenib | C28H22ClF3N6O3 | 1448347-49-6 | Details |
| 2-[(1R)-1-{[5-bromo-2-(di-tert-butyloxycarbonylamino)pyridin-3-yl]oxy}-ethyl]-N-[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl]-4-fluoro-N-methylbenzamide | C31H36BrFN6O6 | 1643141-22-3 | Details |
| Pirtobrutinib | C22H21F4N5O3 | 2101700-15-4 | Details |
| Lanzetinib mesylate hydrate | C31H38N8O6S | 2411549-88-5 | Details |
| 2,2,2-Trifluoro-ethanol formate | C3H3F3O2 | 32042-38-9 | Details |
| SUZETRIGINE | C21H20F5N3O4 | 2649467-58-1 | Details |
| METHYL 5-(TRIFLUOROMETHYL)-1H-INDOLE-7-CARBOXYLATE | C11H8F3NO2 | 3033744-27-0 | Details |
| C22H28FN4O6P | 874819-74-6 | Details |
| Quizartinib Dihydrochloride | C29H33ClN6O4S | 1132827-21-4 | Details |
| Methyldopa | C10H13NO4 | 555-30-6 | Details |
| Fezolinetant | C16H15FN6OS | 1629229-37-3 | Details |
| Inavolisib | C18H19F2N5O4 | 2060571-02-8 | Details |
| trans-(N-Boc-4-aminocyclohexyl)aceticAcid | C13H23NO4 | 189153-10-4 | Details |
| Remibrutinib | C27H27F2N5O3 | 1787294-07-8 | Details |
| Ilunocitinib | C17H17N7O2S | 1187594-14-4 | Details |
| Revumenib | C32H47FN6O4S | 2169919-21-3 | Details |
| Zongertinib | C29H29N9O2 | 2728667-27-2 | Details |
| Vismodegib | C19H14Cl2N2O3S | 879085-55-9 | Details |
| BENZOIC ACID,2-AMINO-4-CHLORO-5-FLUORO- | C7H5ClFNO2 | 108288-16-0 | Details |
| Alpelisib | C19H22F3N5O2S | 1217486-61-7 | Details |
| Oclacitinib | C15H23N5O2S | 1208319-26-9 | Details |
| Gilteritinib hemifumarate | C33H48N8O7 | 1254053-84-3 | Details |
| Boc, N-methylaminoacetone | C9H17NO3 | 532410-39-2 | Details |
| Tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | C12H17BrN4O2 | 1454848-24-8 | Details |
| Ripretinib | C24H21BrFN5O2 | 1442472-39-0 | Details |
| Nerandomilast | C20H26ClN6O2S- | 1423719-30-5 | Details |
| 2-amino-5-bromopyridin-3-yl 4-methylbenzenesulfonate | C12H11BrN2O3S | 2149574-31-0 | Details |
| Zavegepant hydrochloride | C36H47ClN8O3 | 1414976-20-7 | Details |
| 2,4,6-trifluorophenol | C6H3F3O | 2268-17-9 | Details |
| Bdtx-1535 | C30H30ClFN6O2 | 2607829-38-7 | Details |
| BLU-945 | C28H37FN6O3S | 2660250-10-0 | Details |
| 1-tert-Butyl 3-methyl 4-oxopiperidine-1,3-dicarboxylate | C12H19NO5 | 161491-24-3 | Details |
| SODIUM 8-(2-HYDROXYBENZAMIDO) OCTANOATE | C15H22NNaO4 | 203787-91-1 | Details |
| daprodustat | C19H27N3O6 | 960539-70-2 | Details |
| 2-(Bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yl-4-methylbenzenesulfonate | C22H27BrN2O7S | 1803573-21-8 | Details |
| 1-Methyl-4-(piperidin-4-yl)piperazine trihydrochloride | C10H22ClN3 | 1621519-77-4 | Details |
| (R)-N-Boc-3-pyrrolidineacetic acid | C11H19NO4 | 204688-60-8 | Details |
| TAS6417 | C23H20N6O | 1661854-97-2 | Details |
| Sotorasib | C30H30F2N6O3 | 2296729-00-3 | Details |
| (2R,3S,4S,5R)-3-(3,4-Difluoro-2-methoxyphenyl) tetrahydro-4,5-dimethyl -5-(trifluoromethyl)-2-furancarboxylic acid | C15H15F5O4 | 2649470-87-9 | Details |
| Treprostinil | C23H34O5 | 81846-19-7 | Details |
| (R)-3-(1-(5-fluoro-2-iodophenyl)ethoxy)pyridin-2-amine | C13H12FIN2O | 1454847-98-3 | Details |
| Methyl(R)-2-(1-((2-amino-5-bromopyridin-3-yl)oxy)ethyl)-4-fluorobenzoate | C15H14BrFN2O3 | 1454848-00-0 | Details |
| Mirogabalin besylate | C18H25NO5S | 1138245-21-2 | Details |
| Tolebrutinib | C26H25N5O3 | 1971920-73-6 | Details |
| Deucravacitinib | C20H22N8O3 | 1609392-27-9 | Details |
| Belzutifan | C17H12F3NO4S | 1672668-24-4 | Details |
| Mobocertinib succinate | C36H45N7O8 | 2389149-74-8 | Details |
| Ensifentrine | C26H31N5O4 | 1884461-72-6 | Details |
| 2-amino-5-bromopyridin-3-ol | C5H5BrN2O | 39903-01-0 | Details |
| Opnurasib | C29H28ClN7O | 2653994-08-0 | Details |
| NVL655/ALK-IN-27 | C23H22ClFN6O | 2739866-40-9 | Details |
| Trans-Zeatin | C10H13N5O | 1637-39-4 | Details |
| (R)-2-BROMOBUTANOIC ACID | C4H7BrO2 | 2681-94-9 | Details |
| 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline | C17H28N4O | 761440-75-9 | Details |
| Ruxolitinib phosphate | C17H21N6O4P | 1092939-17-7 | Details |
| 3-Amino-6-bromo-1,2,4-triazine | C3H3BrN4 | 69249-22-5 | Details |
| 1-[1-(3-Methoxy-4-nitrophenyl)-4-piperidinyl]-4-methylpiperazine | C17H26N4O3 | 761440-65-7 | Details |
| Tazemetostat | C34H44N4O4 | 1403254-99-8 | Details |
| Elafibranor | C22H24O4S | 824932-88-9 | Details |
| 2-FLUORO-4-(TRIFLUOROMETHYL)PHENYLBORONIC ACID | C7H5BF4O2 | 503309-11-3 | Details |
| Brilaroxazine | C22H25Cl2N3O3 | 1239729-06-6 | Details |
| Filgotinib maleate | C25H27N5O7S | 1802998-75-9 | Details |
| 3-Amino-1,2,4-triazine | C3H4N4 | 1120-99-6 | Details |
| Retatrutide | 2381089-83-2 | Details |
| Atrasentan | C29H38N2O6 | 173937-91-2 | Details |
| (2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonitrile | 2875067-17-5 | Details |
| Semaglutide | C187H291N45O59 | 910463-68-2 | Details |
| Gepirone hydrochloride | C19H30ClN5O2 | 83928-66-9 | Details |
| Asciminib hydrochloride | C20H18ClF2N5O3. HCl | 2119669-71-3 | Details |
| Adagrasib | C32H35ClFN7O2 | 2326521-71-3 | Details |
| 4-Iodo-2-methylaniline | C7H8IN | 13194-68-8 | Details |
| 3-Bromo-4-chlorobenzoic acid | C7H4BrClO2 | 42860-10-6 | Details |
| 1,2-Dibromo-4,5-difluorobenzene | C6H2Br2F2 | 64695-78-9 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 | ||||